REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Investigaciones Microbiologicas Del Cesar Limitada (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Centro De Investigaciones Microbiologicas Del Cesar Limitada Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Centro De Investigaciones Microbiologicas Del Cesar Limitada is based in Colombia, with the head office in Valledupar. It operates in the Ambulatory Health Care Services industry. Centro De Investigaciones Microbiologicas Del Cesar Limitada was incorporated on June 11, 2002. The total number of employees is currently 5 (2017). The latest financial highlights indicate a net sales revenue drop of 12.69% in 2022. Its’ total assets recorded a growth of 13.46%. The net profit margin of Centro De Investigaciones Microbiologicas Del Cesar Limitada decreased by 8.35% in 2022.

Headquarters
Cl 16C 19D 14
Valledupar; Cesar;

Contact Details: Purchase the Centro De Investigaciones Microbiologicas Del Cesar Limitada report to view the information.

Basic Information
Total Employees:
Purchase the Centro De Investigaciones Microbiologicas Del Cesar Limitada report to view the information.
Outstanding Shares:
Purchase the Centro De Investigaciones Microbiologicas Del Cesar Limitada report to view the information.
Incorporation Date:
June 11, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Investigaciones Microbiologicas Del Cesar Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-12.69%
Total operating revenue
-12.69%
Operating profit (EBIT)
-29.05%
EBITDA
-26.49%
Net Profit (Loss) for the Period
-38.29%
Total assets
13.46%
Total equity
15.99%
Operating Profit Margin (ROS)
-8.42%
Net Profit Margin
-8.35%
Return on Equity (ROE)
-12.01%
Quick Ratio
12.53%
Cash Ratio
5.95%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?